CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Vijayawada: The Departments of Physics, Chemistry and Electronics of Andhra Loyola College jointly organised a two-day ...
Fears that the president's return to the White House would seriously damage science agencies and universities have been borne ...
The abrupt change in the U.S. childhood vaccine schedule from 17 vaccines to 11 belies promises to the American people that ...
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
The U.S. cut the number of vaccines it recommends for every child, which could undermine protections against a half-dozen ...
InvestorsHub on MSN
Dow Jones, S&P, Nasdaq, Wall Street futures, markets scan Trump’s Venezuela oil deal as attention turns to a wave of US data
Futures tied to the main U.S. equity indices were struggling to find clear direction on Wednesday, as investors balanced ...
Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing agreement with the Trump ...
This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
US stocks closed mixed on Thursday as investors rotated out of tech as they took in fresh labor market data and grappled with ...
Wall Street ended higher on Tuesday, as chip stocks surged on renewed AI optimism, Moderna rallied and the Dow Jones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback